Baxter International Inc. reported second-quarter 2026 results with worldwide sales of $2.96 billion, a 5% increase on both a reported and organic basis. U.S. GAAP diluted earnings per share were $0.26, while adjusted diluted EPS was $0.56. The company raised its full-year 2026 financial outlook, projecting reported sales growth of 3% to 4%, organic sales growth of 2% to 3%, and adjusted EPS between $1.95 and $2.15. Additionally, the Board declared a quarterly cash dividend of $0.01 per share, payable on October 1, 2026, to stockholders of record as of August 28, 2026. Baxter International Inc. is a global medical technology company providing essential solutions in hospital and physician office settings.

Baxter International Inc. is recasting its historical segment and product category financial information to align with a new operating model effective for the second quarter of 2026. The company has transitioned from three reportable segments (Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals) to two segments: Medical Products & Therapies (MPT) and Healthcare Systems & Technologies (HST). The former Pharmaceuticals segment is now integrated into the MPT segment's Infusion Therapies & Platforms (ITP) division. Baxter International Inc. operates in the medical technology and healthcare solutions industry, providing sterile IV solutions, infusion systems, and patient monitoring technologies.

Baxter International Inc. announced several governance and compensation updates following its 2026 annual meeting, most notably the stockholder approval of an additional 20 million shares reserved for the company's incentive plan. The company also implemented a new Executive Severance and Change in Control Plan that expands the definition of qualifying terminations and establishes tiered cash benefits for senior officers. These developments are significant for investors as they impact potential shareholder dilution and the company's long-term executive exit cost structures.

Baxter International Inc. released its earnings results for the period ended March 31, 2026, and declared a quarterly cash dividend of $0.01 per share. The dividend is payable on July 1, 2026, to stockholders of record as of May 29, 2026, providing investors with updated financial performance data and a scheduled return of capital.

Baxter International announced the departure of CFO Joel Grade, appointing Senior Vice President Anita Zielinski as interim CFO while the company conducts a search for a permanent replacement. Zielinski will receive an additional $50,000 per month and a one-time $250,000 restricted stock unit award to compensate for her expanded responsibilities. This leadership transition is a significant change in the company's executive management that investors will monitor for stability in financial oversight.